Compound Summary
药名: | kainic acid |
别名: | alpha- Kainic acid; K0250_SIGMA; Kainic acid monohydrate; (2S,3S,4S)-3-(carboxymethyl)-4-(prop-1-en-2-yl)pyrrolidine-2-carboxylic acid hydrate; SCHEMBL6081964; (2S,3S,4S)-3-(carboxymethyl)-4-prop-1-en-2-ylpyrrolidine-2-carboxylic acid; InChI=1/C10H15NO4/c1-5(2)7-4-11-9(10(14)15)6(7)3-8(12)13/h6-7,9,11H,1,3-4H2,2H3,(H,12,13)(H,14,15)/t6-,7+,9-/m0/s; L-proline, 3-(carboxymethyl)-4-(1-methylethenyl)-, (3S,4S)-; UPCMLD-DP146:001; D02546; Kainic acid hydrate; C12819; I519JC63XY; MLS001074661; NCGC00024504-05; 4-22-00-01523 (Beilstein Handbook Reference); rel-(3R,4R)-3-(carboxymethyl)-4-isopropenyl-D-proline; NSC136038; EU-0100656; (2S,3S,4R)-Carboxy-4-(1-methylethenyl)-3-pyrrolidineacetic Acid; NCGC00024504-03; Kainic acid [INN:JAN]; DTXSID50206732; 3-Pyrrolidineacetic acid, 2-carboxy-4-(1-methylethenyl)-, monohydrate, (2S-(2alpha,3beta,4beta))-; KAINIC ACID 2-CARBOXY-3-CARBOXYMETHYL-4-ISOPROPENYLPYRROLIDINE; (-)-Kainic acid hydrate; (2S,3S,4S)-3-(carboxymethyl)-4-isopropenyl-2-pyrrolidinecarboxylic acid; 2-Carboxy-3-carboxymethyl-4-isopropenylpyrrolidine; SC-66129; 2-Carboxy-4-isopropenyl-3-pyrrolidineacetic acid; SR-01000075454-9; (2S,3S,4S)-3-(carboxymethyl)-4-prop-1-en-2-yl-pyrrolidine-2-carboxylic acid; BRN 0086660; NSC 136038; 3-Pyrrolidineacetic acid, 2-carboxy-4-isopropenyl-; Lopac0_000656; Acide kainique [INN-French]; MolPort-009-018-775; 58002-62-3; L-alpha-Kainic acid; Kainic acid monohydrate, >=98% (HPLC), from Digenea simplex; 3-Pyrrolidineacetic acid, 2-carboxy-4-(1-methylethenyl)-, hydrate (1:1), (2S,3S,4S)-; nchembio881-comp3; Digenin; HMS3649I10; 3-Pyrrolidineacetic acid, 2-carboxy-4-(1-methylethenyl)-, (2S-(2-alpha,3-beta,4-beta))- (9CI); Digenic acid; NCGC00024504-06; UPCMLD-DP146:002; Acido kainico [INN-Spanish]; BPBio1_001306; C10H15NO4.H2O; Kainic acid hydrate [JAN]; (2S,3S,4S)-3-(carboxymethyl)-4-isopropenyl-proline; 487-79-6; Kainic acid monohydrate, >=99% (TLC); (2S,3S,4S)-3-(carboxymethyl)-4-isopropenyl-pyrrolidine-2-carboxylic acid; 1810AH; Kainate; SMR000471885; Kainic Acid, Natural; UNII-I519JC63XY; 2-Carboxy-4-(1-methylethenyl)-3-pyrrolidineacetic Acid; Acidum kainicum [INN-Latin]; Kainic acid hydrate (JP17); 3-Pyrrolidineacetic acid, 2-carboxy-4-(1-methylethenyl)-, (2S-(2alpha,3beta,4beta))-; KAINIC ACID; Digenin (TN); (2S,3S,4S)-3-(Carboxymethyl)-4-(prop-1-en-2-yl)pyrrolidine-2-carboxylic acid; Helminal; Biomol-NT_000217 |
分子式: | C10H15NO4 |
Smiles: | CC(=C)C1CNC(C1CC(=O)O)C(=O)O |
成分: | HBIN031993 |
OB_score: | 63.38989 |
CAS_id: | 487-79-6 |
SymMap_id: | SMIT00857 |
TCMID_id: | 23082 |
TCMSP_id: | MOL013326 |
PubChem_id: | 10255 |
植物ID | 拉丁名 | 药用植物名 | 药名 | 来源 | 功能与主治 | 使用民族 |
---|
TCMBANKHE004490 | Digenea simplex | 海人草 | To expel roundworm./Ascariasis. | |||
TCMBANKHE006932 | Caulis Piperis Kadsurae;Caulis Piperis futokadsurae | 海风藤 | To relieve rheumatic conditions./Wind-cold-damp impediment, aching sinews in limb joints, hypertonicity of sinews and vessels. | |||
TCMBANKHE006303 | Caloglossa leprieurii | 鹧鸪菜 | To expel roundworm./Ascariasis. | |||
TCMBANKHE008131 | Herba Abri | 鸡骨草 | To remove toxic heat, and to relieve the depressed liver and alleviate pain./Icterohepatitis, stomachache, wind-damp bone pain, stasis pain from knocks and falls, mammary welling abscess. |
疾病ID | 病名 | 疾病类型 | MeSH | 参考文献 |
---|
靶点ID | 基因名 | 基因别名 | 描述 |
---|
TCMBANKGE000029 | GZMB | C11; CCPI; CGL-1; CGL1; CSP-B; CSPB; CTLA1; CTSGL1; HLP; SECT | granzyme B |
TCMBANKGE000051 | IL1B | IL-1; IL1-BETA; IL1F2; IL1beta | interleukin 1 beta |
TCMBANKGE000052 | TNF | DIF; TNF-alpha; TNFA; TNFSF2; TNLG1F | tumor necrosis factor |
TCMBANKGE000075 | IL1RN | DIRA; ICIL-1RA; IL-1RN; IL-1ra; IL-1ra3; IL1F3; IL1RA; IRAP; MVCD4 | interleukin 1 receptor antagonist |
TCMBANKGE000219 | CCR5 | CC-CKR-5; CCCKR5; CCR-5; CD195; CKR-5; CKR5; CMKBR5; IDDM22 | C-C motif chemokine receptor 5 |
TCMBANKGE000221 | GRIA2 | GLUR2; GLURB; GluA2; GluR-K2; HBGR2; gluR-2; gluR-B | glutamate ionotropic receptor AMPA type subunit 2 |
TCMBANKGE000236 | BDNF | ANON2; BULN2 | brain derived neurotrophic factor |
TCMBANKGE000271 | APOE | AD2; APO-E; ApoE4; LDLCQ5; LPG | apolipoprotein E |
TCMBANKGE000274 | CCL2 | GDCF-2; HC11; HSMCR30; MCAF; MCP-1; MCP1; SCYA2; SMC-CF | C-C motif chemokine ligand 2 |
TCMBANKGE000414 | CYP19A1 | ARO; ARO1; CPV1; CYAR; CYP19; CYPXIX; P-450AROM | cytochrome P450 family 19 subfamily A member 1 |
TCMBANKGE000468 | CTSB | APPS; CPSB; RECEUP | cathepsin B |
TCMBANKGE000545 | CXCL2 | CINC-2a; GRO2; GROb; MGSA-b; MIP-2a; MIP2; MIP2A; SCYB2 | C-X-C motif chemokine ligand 2 |
TCMBANKGE000585 | BCL2L11 | BAM; BIM; BOD | BCL2 like 11 |
TCMBANKGE000745 | BAG3 | BAG-3; BIS; CAIR-1; MFM6 | BAG cochaperone 3 |
TCMBANKGE000759 | MAP1LC3B | ATG8F; LC3B; MAP1A/1BLC3; MAP1LC3B-a | microtubule associated protein 1 light chain 3 beta |
TCMBANKGE000813 | DPP4 | ADABP; ADCP2; CD26; DPPIV; TP103 | dipeptidyl peptidase 4 |
TCMBANKGE001103 | MDM2 | ACTFS; HDMX; LSKB; hdm2 | MDM2 proto-oncogene |
TCMBANKGE001132 | BAX | BCL2L4 | BCL2 associated X, apoptosis regulator |
TCMBANKGE001156 | CASP3 | CPP32; CPP32B; SCA-1 | caspase 3 |
TCMBANKGE001166 | BCL2 | Bcl-2; PPP1R50 | BCL2 apoptosis regulator |
TCMBANKGE001169 | BCL2L1 | BCL-XL/S; BCL2L; BCLX; Bcl-X; PPP1R52 | BCL2 like 1 |
TCMBANKGE001177 | TP53 | BCC7; BMFS5; LFS1; P53; TRP53 | tumor protein p53 |
TCMBANKGE001179 | SMAD2 | JV18; JV18-1; MADH2; MADR2; hMAD-2; hSMAD2 | SMAD family member 2 |
TCMBANKGE001184 | RELA | CMCU; NFKB3; p65 | RELA proto-oncogene, NF-kB subunit |
TCMBANKGE001191 | GRIA1 | GLUH1; GLUR1; GLURA; GluA1; HBGR1 | glutamate ionotropic receptor AMPA type subunit 1 |
TCMBANKGE001193 | GDNF | ATF; ATF1; ATF2; HFB1-GDNF; HSCR3 | glial cell derived neurotrophic factor |
TCMBANKGE001393 | NRCAM | - | neuronal cell adhesion molecule |
TCMBANKGE001816 | HRH1 | H1-R; H1R; HH1R; hisH1 | histamine receptor H1 |
TCMBANKGE002133 | HRK | DP5; HARAKIRI | harakiri, BCL2 interacting protein |
TCMBANKGE002494 | PENK | PE; PENK-A | proenkephalin |
TCMBANKGE003089 | ITPKA | IP3-3KA; IP3KA | inositol-trisphosphate 3-kinase A |
TCMBANKGE005458 | MT3 | GIF; GIFB; GRIF; ZnMT3 | metallothionein 3 |
TCMBANKGE005560 | DBT | BCATE2; BCKAD-E2; BCKADE2; BCOADC-E2; E2; E2B | dihydrolipoamide branched chain transacylase E2 |
TCMBANKGE005712 | DNAJB1 | HSPF1; Hdj1; Hsp40; RSPH16B; Sis1 | DnaJ heat shock protein family (Hsp40) member B1 |
TCMBANKGE006565 | NPY | PYY4 | neuropeptide Y |
TCMBANKGE006643 | YWHAZ | 14-3-3-zeta; HEL-S-3; HEL-S-93; HEL4; KCIP-1; POPCHAS; YWHAD | tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein zeta |
TCMBANKGE006736 | BCL2L2 | BCL-W; BCL2-L-2; BCLW; PPP1R51 | BCL2 like 2 |
TCMBANKGE008206 | NTF3 | HDNF; NGF-2; NGF2; NT-3; NT3 | neurotrophin 3 |
TCMBANKGE009562 | C5AR1 | C5A; C5AR; C5R1; CD88 | complement C5a receptor 1 |
TCMBANKGE010521 | SLC5A11 | KST1; RKST1; SGLT6; SMIT2 | solute carrier family 5 member 11 |
TCMBANKGE010692 | KAT5 | ESA1; HTATIP; HTATIP1; PLIP; TIP; TIP60; ZC2HC5; cPLA2 | lysine acetyltransferase 5 |
TCMBANKGE010804 | PRKAG2 | AAKG; AAKG2; CMH6; H91620p; WPWS | protein kinase AMP-activated non-catalytic subunit gamma 2 |
TCMBANKGE010821 | MAP1A | MAP1L; MTAP1A | microtubule associated protein 1A |
TCMBANKGE011079 | PRSS1 | TRP1; TRY1; TRY4; TRYP1 | serine protease 1 |
TCMBANKGE013016 | LIPG | EDL; EL; PRO719 | lipase G, endothelial type |
TCMBANKGE014050 | GABRA1 | ECA4; EIEE19; EJM; EJM5 | gamma-aminobutyric acid type A receptor subunit alpha1 |